(1)
Rice, Z.; Gooderham, M.; Lebwohl, M. G.; Simpson, E. L. .; Boguniewicz, M.; Wollenberg, A.; Lazariciu, I.; Chan, G. L.; Alderfer, J.; Watkins, M. Short-Term Efficacy and Safety of Abrocitinib by Baseline Disease Severity in Patients With Moderate-to-Severe Atopic Dermatitis. J of Skin 2023, 7, s154.